Elvin Kedhi

Elvin Kedhi

Interventional cardiologist / Cardiologist
Royal Victoria Hospital - Montreal, Canada

Latest contributions

DCB after REC-CAGEFREE 1 - Vulnerable plaque PCI after PREVENT

21 May 2025 – From EuroPCR 2025

Reflect on the impact of recent trials REC-CAGEFREE 1 and PREVENT on the use of drug-coated balloons (DCB) and preventive PCI for vulnerable plaque. This session includes case discussions highlighting DCB applications and insights from cutting-edge clinical studies.

DCB after REC-CAGEFREE 1 - Vulnerable plaque PCI after PREVENT

PCR meets China: great innovations and novel trials

21 May 2025 – From EuroPCR 2025

Join this session to explore innovative coronary and valvular device developments originating from China. Learn about the clinical relevance and global impact of these domestic innovations, and engage in knowledge exchange with Chinese colleagues, celebrating longstanding collaboration in cardiology.

PCR meets China: great innovations and novel trials

High-risk plaque assessment with intracoronary imaging

21 May 2025 – From EuroPCR 2025

Explore high-risk plaque assessment using intracoronary imaging modalities such as OCT and AI-driven analysis. This session investigates associations between thin-cap fibroatheroma, local inflammation, and adverse outcomes, highlighting novel biomarkers and imaging techniques that enhance prognostic evaluation and guide personalized coronary artery disease management.

High-risk plaque assessment with intracoronary imaging

Late-breaking trials: TAVI head-to-head

14 May 2024 – From EuroPCR 2024

This session presents the latest findings from several late-breaking trials comparing different transcatheter aortic valve implantation (TAVI) approaches. Topics include outcomes in women with small aortic annuli, the comparison of percutaneous versus surgical treatment for patients with aortic stenosis and coronary disease, the impact of valve...

Late-breaking trials: TAVI head-to-head

TAVI - Patient selection

20 Nov 2023 – From PCR London Valves 2023

Gain essential insights into TAVI patient selection through these selected abstract submissions from PCR London Valves 2023: explore the benefits of guideline-directed therapy for severe aortic stenosis, unravel the significance of subthreshold aortic valve calcium scores in patients with cardiac amyloidosis and aortic stenosis, delve into...

TAVI - Patient selection

Celebrating 30 years of transradial artery access!

17 May 2022

Thirty years ago, the interventional cardiology field was transformed with the emergence of a new access site – the radial artery was used for coronary angioplasty and stent implantation for the first time on 14 August 1992.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
Dr. Ferdinand Kiemeniji

Author

Ferdinand Kiemeneij

Aspirin vs. P2Y12 monotherapy in Onyx-1

26 Jun 2020 – From PCR e-Course 2020

Watch this session if you want to review the highlights of the Onyx ONE Month DAPT Program and to listen to commentary on the SAPT late breaker sub-analysis comparing the safety and efficacy of administering aspirin vs. P2Y12 inhibitor.

Videos included on this page: the Hot Line...

Aspirin vs. P2Y12 monotherapy in Onyx-1

High bleeding risk: a case-based approach

22 May 2019 – From EuroPCR 2019

Consult this session on high bleeding risk patients to learn through various clinical cases more about the risks and benefits of DAPT duration, the strategies in PCI, and more!

High bleeding risk: a case-based approach